WallStreetZenWallStreetZen

NASDAQ: HLVX
Hillevax Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for HLVX

Based on 1 analyst offering 12 month price targets for Hillevax Inc

Min Forecast
$2.00+8.11%
Avg Forecast
$2.00+8.11%
Max Forecast
$2.00+8.11%

Should I buy or sell HLVX stock?

Based on 1 analyst offering ratings for Hillevax Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their HLVX stock forecasts and price targets.

HLVX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-31

1 of 1

Forecast return on equity

Is HLVX forecast to generate an efficient return?

Company
-17.11%
Industry
140.91%
Market
90.47%
HLVX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HLVX forecast to generate an efficient return on assets?

Company
-14.44%
Industry
32.45%
HLVX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HLVX earnings per share forecast

What is HLVX's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.58
Avg 2 year Forecast
-$0.61
Avg 3 year Forecast
-$0.69

HLVX revenue forecast

What is HLVX's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$15.7M
Avg 2 year Forecast
$34.9M
Avg 3 year Forecast
$82.2M

HLVX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
HLVX$1.85$2.00+8.11%Hold
WHWK$1.96N/AN/A
ADAG$1.95$8.00+310.26%Buy
COYA$5.63$16.67+196.04%Strong Buy
IVVD$0.79$7.00+783.84%Strong Buy
View Top Biotech Stocks

Hillevax Stock Forecast FAQ

Is Hillevax Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: HLVX) stock is to Hold HLVX stock.

Out of 1 analyst, 0 (0%) are recommending HLVX as a Strong Buy, 0 (0%) are recommending HLVX as a Buy, 1 (100%) are recommending HLVX as a Hold, 0 (0%) are recommending HLVX as a Sell, and 0 (0%) are recommending HLVX as a Strong Sell.

If you're new to stock investing, here's how to buy Hillevax stock.

What is HLVX's earnings growth forecast for 2025-2027?

(NASDAQ: HLVX) Hillevax's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.33%.

Hillevax's earnings in 2025 is -$106,499,000.On average, 2 Wall Street analysts forecast HLVX's earnings for 2025 to be -$29,081,817, with the lowest HLVX earnings forecast at -$33,594,513, and the highest HLVX earnings forecast at -$24,569,121. On average, 2 Wall Street analysts forecast HLVX's earnings for 2026 to be -$30,335,344, with the lowest HLVX earnings forecast at -$37,605,798, and the highest HLVX earnings forecast at -$23,064,889.

In 2027, HLVX is forecast to generate -$34,346,629 in earnings, with the lowest earnings forecast at -$47,132,600 and the highest earnings forecast at -$21,560,658.

What is HLVX's revenue growth forecast for 2028-2030?

(NASDAQ: HLVX) Hillevax's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.

Hillevax's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast HLVX's revenue for 2028 to be $789,220,347, with the lowest HLVX revenue forecast at $789,220,347, and the highest HLVX revenue forecast at $789,220,347. On average, 2 Wall Street analysts forecast HLVX's revenue for 2029 to be $1,750,675,250, with the lowest HLVX revenue forecast at $1,595,990,067, and the highest HLVX revenue forecast at $1,905,360,432.

In 2030, HLVX is forecast to generate $4,121,846,166 in revenue, with the lowest revenue forecast at $2,226,764,652 and the highest revenue forecast at $6,016,927,680.

What is HLVX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: HLVX) forecast ROA is -14.44%, which is lower than the forecast US Biotechnology industry average of 32.45%.

What is HLVX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year HLVX price target, the average HLVX price target is $2.00, with the highest HLVX stock price forecast at $2.00 and the lowest HLVX stock price forecast at $2.00.

The Wall Street analyst predicted that Hillevax's share price could reach $2.00 by Mar 31, 2026. The average Hillevax stock price prediction forecasts a potential upside of 8.11% from the current HLVX share price of $1.85.

What is HLVX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: HLVX) Hillevax's current Earnings Per Share (EPS) is -$2.16. On average, analysts forecast that HLVX's EPS will be -$0.58 for 2025, with the lowest EPS forecast at -$0.67, and the highest EPS forecast at -$0.49. On average, analysts forecast that HLVX's EPS will be -$0.61 for 2026, with the lowest EPS forecast at -$0.75, and the highest EPS forecast at -$0.46. In 2027, HLVX's EPS is forecast to hit -$0.69 (min: -$0.94, max: -$0.43).

What is HLVX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: HLVX) forecast ROE is -17.11%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.